SCHEMBL21499662

SCHEMBL21499662

CN1c2ncn(Cc3ccc(Cl)cc3)c2C(=O)N(C2CC(OCc3ccccc3)C2)C1O

nearest known ligand 0.46

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 2/20 0.46
▸ TSHR P16473 2/20 0.46
▸ NPSR1 Q6W5P4 1/20 0.37
▸ HPGD P15428 1/20 0.37
▸ SCD O00767 1/20 0.36
▸ MEN1 O00255 1/20 0.36
▸ KMT2A Q03164 1/20 0.36
▸ GPBAR1 Q8TDU6 3/20 0.35
▸ BCHE P06276 2/20 0.35
▸ CYP11B2 P19099 2/20 0.34
▸ MAPK1 P28482 2/20 0.34
▸ CYP11B1 P15538 1/20 0.34
▸ HTT P42858 1/20 0.34
▸ SMN1; SMN2 Q16637 1/20 0.34
▸ MDM4 O15151 1/20 0.33
▸ TP53 P04637 1/20 0.33
▸ MDM2 Q00987 1/20 0.33
▸ LMNA P02545 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23974592 0.75 TSHR (0.57) ALDH1A1TSHRHPGDCYP11B2CYP11B1
SCHEMBL16027911 0.71 LMNA (0.57) ALDH1A1TSHRNPSR1HPGDMAPK1
SCHEMBL16028031 0.69 CNOT7 (0.52) ALDH1A1TSHRNPSR1HPGDSCD
SCHEMBL16076192 0.65 SCD (0.40) ALDH1A1TSHRNPSR1HPGDSCD
SCHEMBL2028682 0.63 PLK1 (0.47) —
SCHEMBL2028685 0.63 PLK1 (0.47) —
SCHEMBL12429365 0.62 ALDH1A1 (0.47) ALDH1A1TSHRSCDCYP11B2MAPK1
SCHEMBL21499649 0.62 MAPK1 (0.43) ALDH1A1TSHRSCDMEN1KMT2A
SCHEMBL713617 0.61 PDE5A (0.63) —
SCHEMBL713618 0.61 PDE5A (0.63) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230040259-A1 SUBSTITUTED XANTHINES AND METHODS OF USE THEREOF HYDRA BIOSCIENCES, LLC (US) 2023-02-09 — — US disclosed
US-11208409-B2 Substituted xanthines and methods of use thereof HYDRA BIOSCIENCES, LLC (US) 2021-12-28 — — US disclosed
US-20190322667-A1 SUBSTITUTED XANTHINES AND METHODS OF USE THEREOF BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2019-10-24 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230040259-A1 SUBSTITUTED XANTHINES AND METHODS OF USE THEREOF TRPC5, TRPC7, TRPC4 ALDH1A1 1647/4885TSHR 4540/4885NPSR1 836/4885
US-11208409-B2 Substituted xanthines and methods of use thereof TRPC5, TRPC7, TRPC4 ALDH1A1 1647/4885TSHR 4540/4885NPSR1 836/4885
US-20190322667-A1 SUBSTITUTED XANTHINES AND METHODS OF USE THEREOF TRPC5, TRPC7, TRPC4 ALDH1A1 1647/4885TSHR 4540/4885NPSR1 836/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback